-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Equal-Weight on Arcus Biosciences, Raises Price Target to $22

Benzinga·05/11/2026 17:06:51
Listen to the news
Morgan Stanley analyst Terence Flynn maintains Arcus Biosciences (NYSE:RCUS) with a Equal-Weight and raises the price target from $20 to $22.